9-128566795-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP2PP3PP5
The NM_001130438.3(SPTAN1):c.55C>T(p.Arg19Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R19Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001130438.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPTAN1 | NM_001130438.3 | c.55C>T | p.Arg19Trp | missense_variant | 2/57 | ENST00000372739.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPTAN1 | ENST00000372739.7 | c.55C>T | p.Arg19Trp | missense_variant | 2/57 | 1 | NM_001130438.3 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 08, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Dec 22, 2023 | Criteria applied: PS4,PS2_MOD,PS3_SUP,PM2_SUP,PP1,PP2 - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Nov 02, 2023 | PS4, PM2, PP2, PP5 - The variant has been reported in ClinVar as Pathogenic by other laboratories (Variation ID 427111). This variant has been previously reported as causative for epileptic encephalopathy, spasticp araplegia and ataxia. (PMID:36331550, 35150594). - |
SPTAN1-related disorder Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2024 | The SPTAN1 c.55C>T variant is predicted to result in the amino acid substitution p.Arg19Trp. This variant has been reported to be de novo and to segregate with disease in multiple individuals and families with spastic paraplegia (Van de Vondel et al. 2022. PubMed ID: 35150594; Table S1, Kaplanis et al. 2020. PubMed ID: 33057194; Supplemental Data 3, Zhou et al. 2022. PubMed ID: 35982159; Morsy et al. 2022. PubMed ID: 36331550). Functional studies suggest this variant disrupts protein function (Morsy et al. 2022. PubMed ID: 36331550). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Pathogenic, criteria provided, single submitter | research | Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL) | Apr 27, 2023 | - - |
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 29, 2024 | Identified in multiple individuals with a neuromuscular phenotype previously tested a GeneDx, including multiple de novo cases with confirmed parentage; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36331550, 35150594, 38168508, 35982159, 33057194) - |
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 19 of the SPTAN1 protein (p.Arg19Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with SPTAN1-related conditions (PMID: 35150594). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 427111). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SPTAN1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at